ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2022
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries.
Open access · hybridAbstract read
In one paragraph
Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 26 citations in OpenAlex.
- Lung function across the life course in Kenya: a series of cross-sectional surveys.ERJ open research · 2026Article
- Severe Asthma Exacerbations: From Risk Factors to Precision Management Strategies.Journal of clinical medicine · 2026Review
- South African Thoracic Society position statement on asthma in children, adolescents and adults.African journal of thoracic and critical care medicine · 2026Article
- Asthma in African children and adolescents: Burden, barriers, and management strategies.African journal of thoracic and critical care medicine · 2026Review
- Multifunctional Boron-based 2D Nanoplatforms Ameliorate Severe Respiratory Inflammation by Targeting Multiple Inflammatory Mediators.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Beliefs surrounding the use of inhaled asthma medication in The Gambia: a qualitative study of asthma patients and healthcare workers.NPJ primary care respiratory medicine · 2024Article
- Challenges and Opportunities in COPD Management in Latin America: A Review of Inhalation Therapies and Advanced Drug Delivery Systems.Pharmaceutics · 2024Review
- Article
- Rate of severe exacerbations, healthcare resource utilisation and clinical outcomes in patients with COPD in low-income and middle-income countries: results from the EXACOS International Study.BMJ open respiratory research · 2024Article
- Decreased prevalence and severity of asthma symptoms among adolescents in Ibadan, Nigeria, 1995-2018.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023Article
- Decline of the chronic respiratory disease mortality in the WHO Western Pacific Region.Journal of thoracic disease · 2023Article
- "Asthma is a very bully disease" - patient experiences of living with chronic respiratory diseases in Cape Town, South Africa.International journal for equity in health · 2023Article
- Clinical standards for the diagnosis and management of asthma in low- and middle-income countries.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023Article
- GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee.The European respiratory journal · 2023Article
- Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update.NPJ primary care respiratory medicine · 2023Review
- World Lung Day: impact of "the big 5 lung diseases" in the context of COVID-19.American journal of physiology. Lung cellular and molecular physiology · 2022Article
Corrections and comments
- Commented on by
Authors and funding
37 authors at 18 institutions in 12 countries.
M StolbrinkClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK, Stellenbosch University, Tygerberg, South Africa.
M J ChinouyaEducation Department, Liverpool School of Tropical Medicine, Liverpool, UK.
S JayasooriyaAcademic Unit of Primary Care, University of Sheffield, Sheffield, UK.
R NightingaleClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK, IcFEM Dreamland Mission Hospital, Kimilili, Kenya.
L Evans-HillNifty Fox Creative, Sheffield, UK.
K AllanHealthcare Consultant, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, The Gambia.
H AllenMedical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, The Gambia.
J BalenSchool of Health and Related Research, University of Sheffield, Sheffield, UK.
T BeaconMedical Aid International, Bedford, UK.
K BissellSchool of Population Health, University of Auckland, Auckland, New Zealand.
J ChakayaClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK, Department of Medicine, Therapeutics and Dermatology, Kenyatta University, Nairobi, Kenya.
C-Y ChiangInternational Union Against Tuberculosis and Lung Disease, Paris, France, Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
M CohenAsociación Latinoamericana del Tórax, Forum of International Respiratory Societies, Guatemala.
G DevereuxClinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
A El SonyThe Epidemiological Laboratory (Epi-Lab) for Public Health, Research and Development, Khartoum Sudan.
D M G HalpinUniversity of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
J R HurstUCL Respiratory, University College London, London, UK.
C KipropIcFEM Dreamland Mission Hospital, Kimilili, Kenya.
A LawsonAstraZeneca, Cambridge, UK.
C MacéInternational Union Against Tuberculosis and Lung Disease, Paris, France.
A MakhanuIcFEM Dreamland Mission Hospital, Kimilili, Kenya.
P MakokhaIcFEM Dreamland Mission Hospital, Kimilili, Kenya.
R MasekelaDepartment of Paediatrics and Child Health, School of Clinical Medicine, University of KwaZulu Natal, Durban, South Africa.
H MemeCentre for Respiratory Diseases Research, Kenya Medical Research Institute, Nairobi, Kenya.
E M KhooDepartment of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, International Primary Care Respiratory Group, Larbert, Scotland, UK.
R NantandaMakerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
S PasternakGlaxoSmithKline, Brentford, UK.
C PerrinInternational Union Against Tuberculosis and Lung Disease, Paris, France.
H ReddelThe Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia, Global Initiative for Asthma (GINA), Fontana, WI, USA.
S RylanceNoncommunicable Diseases Department, World Health Organization, Geneva, Switzerland.
P SchweikertAstraZeneca, Cambridge, UK.
C WereGlaxoSmithKline, Brentford, UK.
S WilliamsInternational Primary Care Respiratory Group, Larbert, Scotland, UK.
T WindersGlobal Allergy & Airways Patient Platform, Vienna, Austria.
A YorganciogluDepartment of Pulmonology, Celal Bayar University Medical Faculty, Manisa, Turkey, Global Alliance Against Chronic Respiratory Diseases, Geneva, Switzerland.
G B MarksInternational Union Against Tuberculosis and Lung Disease, Paris, France, University of New South Wales, Sydney, NSW, Australia.
K MortimerInternational Union Against Tuberculosis and Lung Disease, Paris, France, University of Cambridge, Cambridge, UK.
International Union Against Tuberculosis and Lung Disease · FRLiverpool School of Tropical Medicine · GBAstraZeneca (United Kingdom) · GBGlaxoSmithKline (United Kingdom) · GBMRC Unit the Gambia · GMUniversity of Sheffield · GBKenya Medical Research Institute · KEMakerere University · UGManisa Celal Bayar University · TRStellenbosch University · ZAUniversity College London · GBUniversity of Auckland · NZUniversity of Cambridge · GBUniversity of Exeter · GBUniversity of KwaZulu-Natal · ZAUniversity of Malaya · MYWoolcock Institute of Medical Research · AUWorld Health Organization · CH
Funding
Medical Research CouncilWellcome Trust R 203919/Z/16/ZWorld Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Indexed as
Developing CountriesRespiration DisordersGlobal HealthHumansIncomePoverty
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.